Industry Turnover:

• Healthcare: approx. 50%
• Information Technology: approx. 30%
• Optics and Photographic Technology: approx. 20%

TOP 3 Markets:

• Japan: approx. 35%
• USA: approx. 25%
• Europe: approx. 20%

The HOYA Corporation generates its turnover mainly from three major industries: healthcare, information technology, and optics and photographic technology. The largest share of turnover comes from healthcare, indicating HOYA's strong position in the field of medical devices and technologies.

Regionally, Japan is the most important market for HOYA, followed by the USA and Europe. These markets significantly contribute to the total turnover and reflect the company's global presence and influence.

Production Sites: Japan, Thailand, Vietnam, China, USA

HOYA Corporation is a globally operating company that has strategically placed its production facilities in different countries. The main production sites are located in Japan, where the company originated. In addition, HOYA has significant production capacities in Thailand and Vietnam to benefit from the cost-effective production opportunities in Southeast Asia.

In China and the USA, HOYA also maintains production facilities to directly serve the demand in these large markets. This geographical diversification enables HOYA to efficiently respond to global market requirements while minimizing risks associated with dependence on a single location.

Revenue growth: 8.5% (estimated for 2024)
Profit growth: 10.2% (estimated for 2024)

The HOYA Corporation pursues a growth strategy that heavily focuses on innovation and diversification. The company continuously invests in research and development to expand its product range in the areas of Life Care and Information Technology.

An essential part of the strategy is the expansion into emerging markets, particularly in Asia, to benefit from the increasing demand for medical and technological products. Furthermore, HOYA places great emphasis on strategic partnerships and acquisitions to strengthen its market position and integrate new technologies.

Through these measures, the company expects to increase its market shares and ensure long-term profitable growth.

Main raw materials: Glass, quartz, silicon, metals

Countries of origin: Japan, China, USA, Germany

HOYA Corporation is a leading provider of optical products and medical devices. The main raw materials that HOYA imports include glass, quartz, silicon, and various metals that are essential for the production of optical lenses and medical devices.

Japan and China are significant suppliers of quartz and glass, while the USA and Germany are important sources of specialized metals and technologies. These materials are crucial for the quality and precision of the products manufactured by HOYA.

The geographical diversification of suppliers helps HOYA minimize risks in the supply chain and ensure supply security.

Market share in the optics industry: 20% (2024, estimate)
Research and development investments: 8% of revenue (2024)
Gross margin: 55% (2024)

HOYA Corporation has a significant competitive advantage in the optics and medical technology industry. With an estimated market share of 20% in the optics industry, the company demonstrates a strong market presence. The continuous investments in research and development, accounting for about 8% of revenue, highlight HOYA's commitment to innovation and technological leadership.

The high gross margin of 55% indicates an efficient cost structure and the ability to command premium prices for its products. These factors, combined with a strong brand reputation and global presence, give HOYA a sustainable competitive advantage over its competitors.

Institutional investor share: approx. 60% (2025, estimated)

Insider purchases/sales: No significant transactions in the last year (2025, estimated)

The institutional investor share in HOYA Corporation typically stands at around 60%, indicating the trust of large investment funds and institutional investors in the company. These investors value HOYA's stable market position and innovation capabilities.

In 2025, there were no significant insider transactions, suggesting that the management and other insiders did not make any significant changes to their holdings. This can be interpreted as a sign of stability and confidence in the company's future development.

Market share of HOYA Corporation: 12% (2025, estimated)

Main competitors and their market shares:

1. EssilorLuxottica: 20%
2. Carl Zeiss Meditec: 15%
3. Alcon: 14%
4. HOYA Corporation: 12%
5. Bausch + Lomb: 10%
6. Johnson & Johnson Vision: 9%
7. CooperVision: 8%
8. Menicon: 5%
9. Nikon: 4%
10. Rodenstock: 3%

MOAT of HOYA Corporation:

HOYA Corporation has a significant moat, primarily characterized by its strong market position in the manufacturing of optical products and precision instruments. Their innovation capabilities and wide product range, ranging from eyeglass lenses to medical endoscopes, provide a competitive advantage.

Compared to competitors, HOYA has the advantage of being strongly present in multiple niche markets, providing them with a certain resilience to market fluctuations. EssilorLuxottica, on the other hand, has a stronger moat in terms of brand recognition and distribution network, especially in the eyewear frames sector.

Carl Zeiss Meditec and Alcon excel in technological innovations and strong research and development departments, giving them an advantage in certain segments. Overall, HOYA has a solid moat, but some competitors are better positioned in specific areas.

Revenue Growth: 8% (2024) Profit Growth: 10% (2024) R&D Expenses: 7% of revenue (2024)

In 2024, HOYA Corporation achieved a revenue growth of 8%, attributed to strong demand in its core segments such as Life Care and Information Technology. Profit growth was at 10%, indicating efficiency improvements and cost-cutting measures.

The company continues to heavily invest in research and development, with expenses amounting to 7% of revenue. These investments could secure future innovations and competitive advantages, especially in the areas of optical products and medical technologies.

The solid financial performance and strategic focus on high-growth markets suggest that HOYA Corporation could be an attractive investment opportunity, particularly for investors interested in long-term growth.

Dividend yield: 1.3% (2024)
Dividend growth: 5% annually (average over the last 5 years)

The HOYA Corporation has regularly distributed dividends to its shareholders in recent years. The dividend yield was last around 1.3%, which is moderate compared to other companies in the industry.

HOYA has a solid balance sheet and has shown a consistent dividend growth of an average of 5% per year over the last five years. This indicates a reliable payout, supported by stable earnings and a strong market position in the optical products and healthcare solutions sector.

Analysts expect that HOYA will continue to be able to pay dividends in the coming years and possibly increase them further, depending on the overall economic situation and company performance.